Deutsche Bank
AARD

Deutsche Bank’s Aardvark Therapeutics AARD Stock Holding History

Deutsche Bank’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.5K Buy
17,901
+11,515
+180% +$119K ﹤0.01% 3391
2025
Q4 		$83.8K Buy
6,386
+661
+12% +$8.25K ﹤0.01% 3351
2025
Q3 		$76.1K Hold
5,725
– – ﹤0.01% 3378
2025
Q2 		$77.4K Buy
+5,725
New +$59K ﹤0.01% 3342

Other funds holding AARD

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Deutsche Bank's AARD Position: Q1 2026 in Review

Deutsche Bank increased its Aardvark Therapeutics (AARD) stake by 180% in Q1 2026, buying an estimated $119K and bringing the position to 17,901 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3391.

Deutsche Bank first reported a position in AARD in Q2 2025 and has held it in 4 quarters since. The position peaked at $83.8K in Q4 2025. 79 funds tracked by Wall St. Rank hold AARD as of Q1 2026.

  • Deutsche Bank held 17,901 shares of Aardvark Therapeutics worth $67.5K as of Q1 2026.
  • Deutsche Bank bought 11,515 Aardvark Therapeutics shares in Q1 2026, an estimated $119K.
  • Aardvark Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3391 holding.
  • Deutsche Bank first reported a position in Aardvark Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Deutsche Bank's Aardvark Therapeutics position peaked at $83.8K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.